Device Week, 29 April 2020 – Edwards Manages Dramatic Drop In TAVR Caused By Pandemic

In this edition of the Device Week podcast, Medtech Insight’s Marion Webb and Reed Miller discuss how Edwards Lifesciences is handling the postponement of most transcatheter aortic valve replacement procedures during the pandemic and how it is planning to help customers complete these procedures by the end of 2020. Medtech Insight articles addressed in this episode: Edwards Sees ‘Tough Time’ Ahead For TAVR Patients https://bit.ly/3cZk0fZ Wall Street Tries To Guess The Impact Of Pandemic On Medtech Revenues https://bit.ly/2UwqbAQ UK Court Blocks Edwards’ TAVR Device For Patent Infringement https://bit.ly/2y3CCNk